Skip to main content

Annals of Hematology

Ausgabe 4/2023

Inhalt (35 Artikel)

Open Access Review Article

ERCC6L2-related disease: a novel entity of bone marrow failure disorder with high risk of clonal evolution

Francesco Baccelli, Davide Leardini, Sara Cerasi, Daria Messelodi, Salvatore Nicola Bertuccio, Riccardo Masetti

Review Article

Neonatal hematological parameters: the translational aspect of developmental hematopoiesis

Rozeta Sokou, Stavroula Parastatidou, Aikaterini Konstantinidi, Georgios Ioakeimidis, Andreas G. Tsantes, Dimitra Houhoula, Nicoletta Iacovidou, Argirios E. Tsantes

Open Access Original Article

Use of thrombopoietin receptor agonists in adults with immune thrombocytopenia: a systematic review and Central European expert consensus

Dražen Pulanić, Angelika Bátorová, Imre Bodó, Libor Červinek, Ioana Ionita, Toshko Lissitchkov, Anahit Melikyan, Maria Podolak-Dawidziak

Original Article

Serum cytokine pattern in children with hemophagocytic lymphohistiocytosis

Wenxin Ou, Yunze Zhao, Ang Wei, Honghao Ma, Qing Zhang, Liping Zhang, Hongyun Lian, Dong Wang, Zhigang Li, Tianyou Wang, Rui Zhang

Open Access Original Article

Maternal factors associated with iron deficiency without anaemia in early pregnancy: ECLIPSES study

Lucía Iglesias-Vázquez, Mercedes Gimeno, Pilar Coronel, Ida Henriette Caspersen, Josep Basora, Victoria Arija

Open Access Original Article

Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United States

Amer M. Zeidan, Daniel A. Pollyea, Uma Borate, Alberto Vasconcelos, Ravi Potluri, David Rotter, Zephirin Kiendrebeogo, Lona Gaugler, Thomas Prebet, Maria Strocchia, Gaetano Bonifacio, Clara Chen

Open Access Original Article

Amsacrine-based induction therapy in AML patients with cardiac comorbidities: a retrospective single-center analysis

David Kuron, Alexander Pohlmann, Linus Angenendt, Torsten Kessler, Rolf Mesters, Wolfgang E. Berdel, Matthias Stelljes, Georg Lenz, Christoph Schliemann, Jan-Henrik Mikesch

Original Article

Benefits of dexamethasone on early outcomes in patients with acute myeloid leukemia with hyperleukocytosis: a propensity score matched analysis

Marco Cerrano, Sylvie Chevret, Emmanuel Raffoux, Florence Rabian, Marie Sébert, Sandrine Valade, Raphael Itzykson, Virginie Lemiale, Lionel Adès, Nicolas Boissel, Hervé Dombret, Elie Azoulay, Etienne Lengliné

Original Article

Impact of gemtuzumab ozogamicin consolidation on hematopoietic stem cells (HSCs) mobilization in AML: analysis of 20 patients

Salvatore Perrone, Saveria Capria, Massimo Bernardi, Francesco Marchesi, Elettra Ortu La Barbera, Silvia Maria Trisolini, Clara Minotti, Mahnaz Shafii Bafti, Maria Cristina Scerpa, Antonino Mulé, Fabio Ciceri, Maurizio Martelli, Giuseppe Cimino

Original Article

Molecular genetics and management of world health organization defined atypical chronic myeloid leukemia

Yingxin Sun, Qinrong Wang, Xingxia Zhang, Zhiyu Zhang, Qian Wang, Jiannong Cen, Mingqing Zhu, Jinlan Pan, Dandan Liu, Depei Wu, Yifeng Cai, Suning Chen

Original Article

Prognostic value of interim 18F-FDG PET/CT in adult follicular lymphoma treated with R-CHOP

Na Sun, Wenli Qiao, Yan Xing, Taisong Wang, Jinhua Zhao

Original Article

Characteristics of inpatients with newly diagnosed multiple myeloma in hematology, nephrology, and orthopedic departments

Yanjie Zhang, Juan Pan, Haixin Kang, Shuotao Peng, Tao-Hsin Tung, Bo Shen

COVID-19 Original Article

COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group

Martin Šimkovič, Peter Turcsányi, Martin Špaček, Jana Mihályová, Pavlína Ryznerová, Mária Maco, Pavel Vodárek, Dominika Écsiová, Hynek Poul, Heidi Móciková, Jana Zuchnická, Anna Panovská, Mohammad Lekaa, Martina Oršulová, Adéla Prchlíková, Lukáš Stejskal, Stanislava Mašlejová, Yvona Brychtová, Lucie Bezděková, Tomáš Papajík, Daniel Lysák, Marek Trněný, Lukáš Smolej, Michael Doubek

Open Access COVID-19 Original Article

Humoral response to mRNA-based COVID-19 vaccine and booster effect of a third dose in patients with mature T cell and NK-cell neoplasms

Mirei Kobayashi, Akio Mori, Masahiro Onozawa, Shihori Tsukamoto, Hajime Senjo, Takashi Ishio, Emi Yokoyama, Minoru Kanaya, Koh Izumiyama, Makoto Saito, Haruna Muraki, Masanobu Morioka, Takanori Teshima, Takeshi Kondo

Original Article

Ibrutinib in relapsed/refractory patients with Waldenström macroglobulinemia: a real-life, retrospective study on behalf of the “RTL” (regional Tuscan lymphoma network)

Emanuele Cencini, Ilaria Romano, Francesco Ghio, Chiara Camerini, Ilaria Bertaggia, Roberta Giachetti, Lara Mannelli, Maria Teresa Pirrotta, Giulia Lucco Navei, Manuel Ciceri, Giulia Cervetti, Emanuela Sant’Antonio, Federico Simonetti, Silvia Birtolo, Benedetta Puccini, Monica Bocchia, Alberto Fabbri

Original Article

Low T3 syndrome as a predictor of poor outcomes in patients with follicular lymphoma

Lian-Guo Xue, Hao-Rui Shen, Rui Gao, Kai-Xin Du, Tong-Yao Xing, Wei-Ting Wang, Li Wang, Jian-Yong Li, Jin-Hua Liang, Wei Xu

Open Access Original Article

Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA

Kenshi Suzuki, Ashutosh D. Wechalekar, Kihyun Kim, Chihiro Shimazaki, Jin Seok Kim, Takayuki Ikezoe, Chang-Ki Min, Fude Zhou, Zhen Cai, Xiaonong Chen, Shinsuke Iida, Nagaaki Katoh, Tomoaki Fujisaki, Ho-Jin Shin, NamPhuong Tran, Xiang Qin, Sandra Y. Vasey, Brenda Tromp, Brendan M. Weiss, Raymond L. Comenzo, Efstathios Kastritis, Jin Lu

Open Access Original Article

Long-term clinical outcomes of gastric mucosa-associated lymphoid tissue lymphoma in real-world experience

Gi-June Min, Donghoon Kang, Han Hee Lee, Seung-Jun Kim, Tong Yoon Kim, Young-Woo Jeon, Joo Hyun O, Byung-Ock Choi, Gyeongsin Park, Seok-Goo Cho

Original Article

Risks and outcomes of hospitalizations in patients with chronic lymphocytic leukemia admitted with immune thrombocytopenia: an analysis of the National Inpatient Sample Database

Mohammad Ammad Ud Din, Amir Mahmud, Mariam Mostafa, Moazzam Shahzad, Hania Liaqat, Javier Pinilla-Ibarz, Michael Jaglal

Original Article

Real-world outcomes of adult patients with acute lymphoblastic leukemia treated with a modified CALGB 10102 regimen

Daniel R. Reed, Margaux Wooster, Scott Isom, Leslie R. Ellis, Dianna S. Howard, Megan Manuel, Sarah Dralle, Susan Lyerly, Rupali Bhave, Bayard L. Powell, Timothy S. Pardee

Original Article

Prognostic factors for patients with hematologic malignancies admitted to the intensive care unit: is allogeneic transplantation still a risk factor?

Pei-Hua Wu, Wen-Xuan Huo, Xiao-Dong Mo, Yu Wang, Chen-Hua Yan, Hao Jiang, Meng-Zhu Shen, Xiao-Jun Huang, You-Zhong An

Original Article

Impact of age on hospitalization and outcomes post allogeneic hematopoietic cell transplantation outcome, a single center experience

Eshrak Al-Shaibani, Shiyi Chen, Carol Chen, Ivan Pasic, Fotios V. Michelis, Wilson Lam, Arjun Law, Igor Novitzky-Basso, Armin Gerbitz, Dennis D. Kim, Auro Viswabandya, Jeffrey H. Lipton, Jonas Mattson, Rajat Kumar

Open Access Original Article

The prognostic value of patient-reported outcomes in allogeneic hematopoietic stem cell transplantation: exploratory analysis of a randomized nutrition intervention trial

Anne Marte Gudmundstuen, Fabio Efficace, Geir Erland Tjønnfjord, Kristin Joan Skaarud, Francesco Cottone, Marianne Jensen Hjermstad, Per Ole Iversen

Original Article

Improved Vδ2+ T cells recovery correlates to reduced incidences of mortality and relapse in acute myeloid leukemia after hematopoietic transplantation

Keli Yue, Haitao Gao, Shuang Liang, Ning Wu, Cong Cheng, Lan-Ping Xu, Xiao-Hui Zhang, Yu Wang, Yifei Cheng, Xiao-Jun Huang, Jiangying Liu

Original Article

Pain: a neglected symptom in hemophilia

Mustafa Kurçaloğlu, Memiş Hilmi Atay

Original Article

Tocilizumab, an IL6-receptor antibody, proved effective as adjuvant therapy for cytokine storm induced by severe infection in patients with hematologic malignancy

Bingjie Wang, Qian Wang, Zeyin Liang, Yue Yin, Lihong Wang, Qingya Wang, Yuan Li, Jinping Ou, Hanyun Ren, Yujun Dong

Letter to the Editor

Early leukoencephalopathy during daratumumab treatment in a patient with multiple myeloma

Shanshan Liu, Hongwei Zhou, Weiling Xu, Tao Jin, Xinyue Liang, Xiaoxia Zhao, Yun Dai, Fengyan Jin

Letter to the Editor

Clonal evolution analysis of a rare acute promyelocytic leukemia patient transforming from essential thrombocythemia

Rong Zhang, Yabin Liu, Huan Song, Yun Tan, Wen Jin, Huiying Zhao, Xiaowu Liu, Jing Li, Gangfeng Wang, Li Chen, Yingmin Liang, Kankan Wang

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

RAS-Blocker bei Hyperkaliämie möglichst nicht sofort absetzen

14.05.2024 Hyperkaliämie Nachrichten

Bei ausgeprägter Nierenfunktionsstörung steigen unter der Einnahme von Renin-Angiotensin-System(RAS)-Hemmstoffen nicht selten die Serumkaliumspiegel. Was in diesem Fall zu tun ist, erklärte Prof. Jürgen Floege beim diesjährigen Allgemeinmedizin-Update-Seminar.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.